Polymeric IgA1 from patients with IgA nephropathy upregulates transforming growth factor-beta synthesis and signal transduction in human mesangial cells via the renin-angiotensin system.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of the American Society of Nephrology

• Publication date

  2003-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/01.ASN.0000095639.56212.BFPMID 14638911
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy.

  2003cited by this paper
• Smad7 inhibits fibrotic effect of TGF-Beta on renal tubular epithelial cells by blocking Smad2 activation.

  2002cited by this paper
• Blockade of TGF-β Signaling in T Cells Prevents the Development of Experimental Glomerulonephritis1

  2001cited by this paper
• Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.

  2001cited by this paper
• Expression of aquaporin-1 in human peritoneal mesothelial cells and its upregulation by glucose in vitro.

  2001cited by this paper
• Molecular Genetics in IgA Nephropathy

  2001cited by this paper
• Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy.

  2001influential reference
• Controlling TGF-β signaling

  2000cited by this paper
• Absence of CD89, polymeric immunoglobulin receptor, and asialoglycoprotein receptor on human mesangial cells.

  2000cited by this paper
• Changes of cytokine profiles during peritonitis in patients on continuous ambulatory peritoneal dialysis.

  2000cited by this paper
• Controlling TGF-beta signaling.

  2000cited by this paper
• Role of angiotensin II in diabetic nephropathy.

  2000cited by this paper
• ff ects of angiotensin II blockade on nitric oxide blood levels in IgA nephropathy

  2000cited by this paper
• Integrin expression and IgA nephropathy: in vitro modulation by IgA with altered glycosylation and macromolecular IgA.

  2000cited by this paper
• IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23

  2000cited by this paper
• Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy.

  1999cited by this paper
• A solid-phase immobilized epitope immunoassay (SPIE-IA) permitting very sensitive and specific measurement of angiotensin II in plasma.

  1999cited by this paper
• Transforming growth factor-beta regulates tubular epithelial-myofibroblast transdifferentiation in vitro.

  1999cited by this paper
• Role of the Janus kinase (JAK)/signal transducters and activators of transcription (STAT) cascade in advanced glycation end-product-induced cellular mitogenesis in NRK-49F cells.

  1999cited by this paper
• Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis.

  1999cited by this paper
• IgA induced activation of human mesangial cells: Independent of FcαR1 (CD 89)

  1998cited by this paper
• IgA induced activation of human mesangial cells: independent of FcalphaR1 (CD 89).

  1998cited by this paper
• Gene expression of the renin‐angiotensin system in human kidney

  1998cited by this paper
• Identification and Functional Characterization of a Smad Binding Element (SBE) in the JunB Promoter That Acts as a Transforming Growth Factor-β, Activin, and Bone Morphogenetic Protein-inducible Enhancer*

  1998cited by this paper
• Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

  1997cited by this paper
• Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

  1997cited by this paper
• Interaction of IgA with Fc alpha receptors of human mesangial cells activates transcription factor nuclear factor-kappa B and induces expression and synthesis of monocyte chemoattractant protein-1, IL-8, and IFN-inducible protein 10.

  1997cited by this paper
• HPLC determination of captopril in human plasma and its pharmacokinetic study.

  1996cited by this paper
• Increased binding of polymeric λ-IgA to cultured human mesangial cells in IgA nephropathy

  1996cited by this paper
• Increased binding of polymeric lambda-IgA to cultured human mesangial cells in IgA nephropathy.

  1996cited by this paper
• Stimulation of Fc(alpha) receptors induces tyrosine phosphorylation of phospholipase C-gamma(1), phosphatidylinositol phosphate hydrolysis, and Ca2+ mobilization in rat and human mesangial cells.

  1996cited by this paper
• Effect of angiotensin-converting enzyme and calcium channel inhibition on progression of IgA nephropathy.

  1995cited by this paper
• Pharmacokinetics of losartan, an angiotensin II receptor antagonist, and its active metabolite EXP3174 in humans

  1995cited by this paper
• Heat-aggregated IgA prepared from patients with IgA nephropathy increases priming of human neutrophils to produce inositol triphosphate following FMet-Leu-Phe stimulation in vitro.

  1995cited by this paper
• Increased mRNA encoding for transforming factor-beta in CD4+ cells from patients with IgA nephropathy.

  1994cited by this paper
• Charge distribution of IgA-lambda in IgA nephropathy.

  1994cited by this paper
• Increased expression of transforming growth factor-beta in renal disease.

  1994cited by this paper
• Increased mRNA encoding for transforming factor-β in CD4+ cells from patients with IgA nephropathy

  1994cited by this paper
• Detection of urinary interleukin-8 in glomerular diseases.

  1994cited by this paper
• Binding of dimeric and polymeric IgA to rat renal mesangial cells enhances the release of interleukin 6.

  1994cited by this paper
• Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation.

  1994cited by this paper
• Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells.

  1994cited by this paper
• Heat-aggregated IgA prepared from patients with IgA nephropathy increases calcium mobilization and superoxide production of human neutrophils in vitro.

  1993cited by this paper
• Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist

  1992cited by this paper
• A retrospective analysis of the natural history of primary IgA nephropathy worldwide.

  1990cited by this paper
• Pharmacokinetics of Captopril in Healthy Subjects and in Patients with Cardiovascular Diseases

  1988cited by this paper
• Studies of lymphocyte subpopulations and immunoglobulin production in IgA nephropathy.

  1987cited by this paper
• Increased immunoglobulin-secreting cells in the blood of patients with active idiopathic IgA nephropathy.

  1986cited by this paper
• Charge and size of mesangial IgA in IgA nephropathy.

  1985cited by this paper
• Nephrotic range proteinuria--a good predictive index of disease in IgA nephropathy?

  1985cited by this paper
• Circulating and mesangial secretory component-binding IgA-1 in primary IgA nephropathy.

  1984cited by this paper
• Increase of IgA-bearing peripheral blood lymphocytes in families of patients with IgA nephropathy.

  1979cited by this paper

• Clinical significance of focal segmental glomerulosclerosis subclassification in IgA nephropathy.

  2025cites this paper
• Mathematical modeling of impacts of patient differences on renin-angiotensin system and applications to COVID-19 lung fibrosis outcomes

  2025cites this paper
• Cell-type-specific molecular characterization of cells from circulation and kidney in IgA nephropathy with nephrotic syndrome

  2023cites this paper
• RhoA vesicle trafficking–mediated transglutaminase 2 membrane translocation promotes IgA1 mesangial deposition in IgA nephropathy

  2023cites this paper
• Influence of IgA nephropathy on the progression of pulpitis and apical periodontitis in HIGA mice.

  2023cites this paper
• Iron metabolism and chronic inflammation in IgA nephropathy

  2023cites this paper
• Potential of bone morphogenetic protein-7 in treatment of lupus nephritis: addressing the hurdles to implementation

  2023cites this paper
• Chemokine (C–C motif) receptor 2 is associated with the pathological grade and inflammatory response in IgAN children

  2022cites this paper
• Mathematical Modeling of Impacts of Patient Differences on Renin-Angiotensin System and Applications to COVID-19 Lung Fibrosis Outcomes

  2022cites this paper
• Identifying Therapeutic Strategies in IgA Nephropathy through Comprehensive Transcriptomic Characterization

  2021cites this paper
• Secretory IgA accumulated in the airspaces of idiopathic pulmonary fibrosis and promoted VEGF, TGF‐β and IL‐8 production by A549 cells

  2020cites this paper
• Identifying hub genes associated with clinical characteristics in IgA nephropathy by WGCNA

  2020cites this paper
• New therapeutic perspectives for IgA nephropathy in children

  2020cites this paper
• The levels of urinary joining chain containing IgG immune complexes are associated with disease severity in IgA nephropathy

  2019cites this paper
• The Role Of Kca3.1 In IGA Nephropathy

  2019cites this paper
• Identifying hub genes associated with clinical characteristicsin IgA nephropathy by Weighted Gene Co-expression Network Analysis

  2019cites this paper
• Higher serum galactose-deficient immunoglobulin A1 concentration is associated with stronger mesangial cellular inflammatory response and more severe histologic findings in immunoglobulin A nephropathy

  2018cites this paper
• Genetic and acquired abnormalities in C3 glomerulopathy and primary immune complex-mediated MPGN

  2018cites this paper
• CCL20 secreted from IgA1-stimulated human mesangial cells recruits inflammatory Th17 cells in IgA nephropathy

  2017cites this paper
• Inflammation in IgA nephropathy

  2017cites this paper
• The mTOR/p70S6K1 signaling pathway in renal fibrosis of children with immunoglobulin A nephropathy

  2017cites this paper
• Evidence-based clinical practice guidelines for IgA nephropathy 2014

  2016cites this paper
• Epithelial-mesenchymal transition in pediatric nephropathies.

  2016cites this paper
• IgA nephropathy

  2016cites this paper
• Mesangial cells from patients with IgA nephropathy have increased susceptibility to galactose-deficient IgA1

  2016cites this paper
• Effect of Immunosuppressive Drugs on the Changes of Serum Galactose-Deficient IgA1 in Patients with IgA Nephropathy

  2016cites this paper
• Ο ρόλος της ελλιπούς γαλακτοζυλίωσης της IgA1 ανοσοσφαιρίνης στην παθογένεια κλινική εικόνα και εξέλιξη της IgA νεφροπάθειας

  2016cites this paper
• Histone deacetylase inhibitors attenuate P-aIgA1-induced cell proliferation and extracellular matrix synthesis in human renal mesangial cells in vitro

  2016cites this paper
• Complement-C1q TNF-Related Protein 3 Alleviates Mesangial Cell Activation and Inflammatory Response Stimulated by Secretory IgA

  2016cites this paper
• Novel mutations in the inverted formin 2 gene of Chinese families contribute to focal segmental glomerulosclerosis.

  2015cites this paper
• Immunoglobulin A nephropathy: current progress and future directions.

  2015cites this paper
• Update on immunoglobulin A nephropathy, Part I: Pathophysiology.

  2015cites this paper
• Combined blockade of angiotensin II and prorenin receptors ameliorates podocytic apoptosis induced by IgA-activated mesangial cells

  2015cites this paper
• Immunoglobulin A Nephropathies in Children (Includes HSP)

  2014cites this paper
• Urokinase-type plasminogen activator receptor in IgA nephropathy

  2014cites this paper
• Association of C4d deposition with clinical outcomes in IgA nephropathy.

  2014cites this paper
• Role of podocyte injury in IgA nephropathy.

  2013cites this paper
• Currently available and potential future treatment options for IgA nephropathy

  2013cites this paper
• C509T and T869C polymorphisms of transforming growth factor &bgr;1 and the risk of IgA nephropathy: a meta‐analysis

  2013cites this paper
• Synergistic Effect of Mesangial Cell-Induced CXCL1 and TGF-β1 in Promoting Podocyte Loss in IgA Nephropathy

  2013cites this paper
• Pathogenesis of IgA nephropathy

  2012cites this paper
• Spleen Tyrosine Kinase Is Important in the Production of Proinflammatory Cytokines and Cell Proliferation in Human Mesangial Cells following Stimulation with IgA1 Isolated from IgA Nephropathy Patients

  2012cites this paper
• Isolated from IgA Nephropathy Patients Cells following Stimulation with IgA1 and Cell Proliferation in Human Mesangial Production of Proinflammatory Cytokines Spleen Tyrosine Kinase Is Important in the

  2012cites this paper
• Studies of the pathogenesis of IgA nephropathy and Henoch-Schönlein purpura, with special reference to Streptococcus pyogenes infections and complement

  2012cites this paper
• A candidate gene approach to genetic contributors to the development of IgA nephropathy.

  2012cites this paper
• The Glomerular Filtration Barrier: Components and Crosstalk

  2012cites this paper
• Additive effect of PPAR-γ agonist and ARB in treatment of experimental IgA nephropathy

  2011cites this paper
• Oxidative damages in tubular epithelial cells in IgA nephropathy: role of crosstalk between angiotensin II and aldosterone

  2011cites this paper
• The pathogenesis of IgA nephropathy: what is new and how does it change therapeutic approaches?

  2011cites this paper
• Primary IgA nephropathy: new insights into pathogenesis.

  2011cites this paper
• Recent advances in IgA nephropathy--the glomerulopodocytic-tubular communication.

  2011cites this paper
• Does Arkadia contribute to TGF-β1-induced IgA expression through up-regulation of Smad signaling in IgA nephropathy?

  2010cites this paper
• Mesangial cells stimulated by immunoglobin A1 from IgA nephropathy upregulates transforming growth factor-beta1 synthesis in podocytes via renin-angiotensin system activation.

  2010cites this paper
• Podocyte number predicts progression of proteinuria in IgA nephropathy

  2010cites this paper
• Meta-analysis of Tripterygium wilfordii Hook F in the immunosuppressive treatment of IgA nephropathy.

  2010cites this paper
• Serum IgA1 from patients with IgA nephropathy up-regulates integrin-linked kinase synthesis and inhibits adhesive capacity in podocytes through indirect pathways.

  2009cites this paper
• Clinical remission and pathological progression after tonsillectomy in a renal transplant patient with recurrent IgA nephropathy

  2009cites this paper
• Beneficial effect of pioglitazone in proteinuric IgA nephropathy with concomitant ACEI/ARB treatment.

  2009cites this paper
• Treatment for IgA Nephropathy: Renin-Angiotensin Blockade

  2009cites this paper
• Immunoglobulin A Nephropathy

  2009cites this paper
• Macromolecular IgA1 taken from patients with familial IgA nephropathy or their asymptomatic relatives have higher reactivity to mesangial cells in vitro.

  2009cites this paper
• Recent Advances in IgA Nephropathy

  2009cites this paper
• Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy

  2009influential citation
• Crosstalk between peroxisome proliferator-activated receptor-gamma and angiotensin II in renal tubular epithelial cells in IgA nephropathy.

  2009cites this paper
• Protective effect of peroxisome proliferator-activated receptor-gamma agonists on activated renal proximal tubular epithelial cells in IgA nephropathy.

  2009influential citation
• Detecção de Complemento - C4d em Capilares Peritubulares e Análise Morfológica de Biópsias de Enxerto Renal

  2009cites this paper
• BMP-7 protects mesangial cells from injury by polymeric IgA.

  2008cites this paper
• Synthesis of TNF-alpha by mesangial cells cultured with polymeric anionic IgA--role of MAPK and NF-kappaB.

  2008cites this paper
• Chapter The role of SIgA and complement in IgA-nephropathy

  2008cites this paper
• Immune regulation in IgA nephropathy

  2008cites this paper
• Cytokines and Growth Factors

  2008cites this paper
• Mesangial C4d deposition: a new prognostic factor in IgA nephropathy.

  2008cites this paper
• Title The protective role of bone morphogenetic protein-7 against mesangial cell injury in IgA nephropathy

  2008cites this paper
• Common patterns of glomerular gene expression profiles in different murine models of early nephropathy

  2008cites this paper
• The role of secretory IgA and complement in IgA nephropathy.

  2008cites this paper
• Chronic thrombopoietin overexpression induces mesangioproliferative glomerulopathy in mice

  2007cites this paper
• Clinicopathological influence of obesity in IgA nephropathy: comparative study of 74 patients.

  2007cites this paper
• Pathogenic role of (S)IgA in IgA nephropathy

  2007influential citation
• Somewhere Over the Rainbow: From Bedside to Bench

  2007cites this paper
• Glycosylation Profile of Differently Charged IgA1 and Their Binding Characteristics to Cultured Mesangial Cells in IgA Nephropathy

  2007cites this paper
• Synthesis of TNF-α by mesangial cells cultured with polymeric anionic IgA—role of MAPK and NF-κB

  2007influential citation
• Effects of therapeutic agents on the inflammatory and fibrogenic factors in IgA nephropathy

  2007cites this paper
• Glomerular activation of the lectin pathway of complement in IgA nephropathy is associated with more severe renal disease.

  2006cites this paper
• Modulating the Progression in IgA Nephropathy

  2006cites this paper
• Pathogenic IgA in IgA nephropathy: still the blind men and the elephant?

  2006cites this paper
• A pathogenic role for secretory IgA in IgA nephropathy.

  2006cites this paper
• The study of Chinese medicinal herbal formula Shen San Fang in the treatment of experimental IgA nephropathy.

  2005cites this paper
• Mechanisms of tubulointerstitial injury in IgA nephropathy.

  2005cites this paper
• Tubular expression of angiotensin II receptors and their regulation in IgA nephropathy.

  2005cites this paper
• Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy.

  2005cites this paper
• IgA: an immune glycoprotein.

  2005cites this paper
• Molecular basis of IgA nephropathy.

  2005cites this paper
• Clinicopathological influence of excess body weight in IgA nephropathy: Comparative study of 68 patients

  2005cites this paper
• Novel mechanisms of tubulointerstitial injury in IgA nephropathy: a new therapeutic paradigm in the prevention of progressive renal failure

  2004cites this paper
• Mesangial expression of angiotensin II receptor in IgA nephropathy and its regulation by polymeric IgA1.

  2004cites this paper
• Association between transforming growth factor beta1 gene polymorphisms and IgA nephropathy.

  2004cites this paper